First Time Loading...

Enzo Biochem Inc
NYSE:ENZ

Watchlist Manager
Enzo Biochem Inc Logo
Enzo Biochem Inc
NYSE:ENZ
Watchlist
Price: 1.06 USD -2.75% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which focuses on delivering and applying advanced technology capabilities to produce affordable reliable produ... [ Read More ]

The intrinsic value of one ENZ stock under the Base Case scenario is 1.48 USD. Compared to the current market price of 1.06 USD, Enzo Biochem Inc is Undervalued by 28%.

Key Points:
ENZ Intrinsic Value
Base Case
1.48 USD
Undervaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Enzo Biochem Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ENZ stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Enzo Biochem Inc

Provide an overview of the primary business activities
of Enzo Biochem Inc.

What unique competitive advantages
does Enzo Biochem Inc hold over its rivals?

What risks and challenges
does Enzo Biochem Inc face in the near future?

Has there been any significant insider trading activity
in Enzo Biochem Inc recently?

Summarize the latest earnings call
of Enzo Biochem Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Enzo Biochem Inc.

Provide P/S
for Enzo Biochem Inc.

Provide P/E
for Enzo Biochem Inc.

Provide P/OCF
for Enzo Biochem Inc.

Provide P/FCFE
for Enzo Biochem Inc.

Provide P/B
for Enzo Biochem Inc.

Provide EV/S
for Enzo Biochem Inc.

Provide EV/GP
for Enzo Biochem Inc.

Provide EV/EBITDA
for Enzo Biochem Inc.

Provide EV/EBIT
for Enzo Biochem Inc.

Provide EV/OCF
for Enzo Biochem Inc.

Provide EV/FCFF
for Enzo Biochem Inc.

Provide EV/IC
for Enzo Biochem Inc.

Show me price targets
for Enzo Biochem Inc made by professional analysts.

What are the Revenue projections
for Enzo Biochem Inc?

How accurate were the past Revenue estimates
for Enzo Biochem Inc?

What are the Net Income projections
for Enzo Biochem Inc?

How accurate were the past Net Income estimates
for Enzo Biochem Inc?

What are the EPS projections
for Enzo Biochem Inc?

How accurate were the past EPS estimates
for Enzo Biochem Inc?

What are the EBIT projections
for Enzo Biochem Inc?

How accurate were the past EBIT estimates
for Enzo Biochem Inc?

Compare the revenue forecasts
for Enzo Biochem Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Enzo Biochem Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Enzo Biochem Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Enzo Biochem Inc compared to its peers.

Compare the P/E ratios
of Enzo Biochem Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Enzo Biochem Inc with its peers.

Analyze the financial leverage
of Enzo Biochem Inc compared to its main competitors.

Show all profitability ratios
for Enzo Biochem Inc.

Provide ROE
for Enzo Biochem Inc.

Provide ROA
for Enzo Biochem Inc.

Provide ROIC
for Enzo Biochem Inc.

Provide ROCE
for Enzo Biochem Inc.

Provide Gross Margin
for Enzo Biochem Inc.

Provide Operating Margin
for Enzo Biochem Inc.

Provide Net Margin
for Enzo Biochem Inc.

Provide FCF Margin
for Enzo Biochem Inc.

Show all solvency ratios
for Enzo Biochem Inc.

Provide D/E Ratio
for Enzo Biochem Inc.

Provide D/A Ratio
for Enzo Biochem Inc.

Provide Interest Coverage Ratio
for Enzo Biochem Inc.

Provide Altman Z-Score Ratio
for Enzo Biochem Inc.

Provide Quick Ratio
for Enzo Biochem Inc.

Provide Current Ratio
for Enzo Biochem Inc.

Provide Cash Ratio
for Enzo Biochem Inc.

What is the historical Revenue growth
over the last 5 years for Enzo Biochem Inc?

What is the historical Net Income growth
over the last 5 years for Enzo Biochem Inc?

What is the current Free Cash Flow
of Enzo Biochem Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Enzo Biochem Inc.

Financials

Balance Sheet Decomposition
Enzo Biochem Inc

Current Assets 80.9m
Cash & Short-Term Investments 60.2m
Receivables 5.1m
Other Current Assets 15.6m
Non-Current Assets 18.2m
PP&E 16m
Other Non-Current Assets 2.1m
Current Liabilities 25.3m
Accounts Payable 1.3m
Accrued Liabilities 8.4m
Short-Term Debt 3.2m
Other Current Liabilities 12.4m
Non-Current Liabilities 3m
Long-Term Debt 234k
Other Non-Current Liabilities 2.8m
Efficiency

Earnings Waterfall
Enzo Biochem Inc

Revenue
63.5m USD
Cost of Revenue
-42.6m USD
Gross Profit
20.9m USD
Operating Expenses
-57.6m USD
Operating Income
-36.7m USD
Other Expenses
32.1m USD
Net Income
-4.6m USD

Free Cash Flow Analysis
Enzo Biochem Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ENZ Profitability Score
Profitability Due Diligence

Enzo Biochem Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Negative 1-Year Revenue Growth
Negative ROE
18/100
Profitability
Score

Enzo Biochem Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

ENZ Solvency Score
Solvency Due Diligence

Enzo Biochem Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
52/100
Solvency
Score

Enzo Biochem Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ENZ Price Targets Summary
Enzo Biochem Inc

Wall Street analysts forecast ENZ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENZ is 5.5 USD .

Lowest
Price Target
Not Available
Average
Price Target
5.5 USD
419% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ENZ Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ENZ Price
Enzo Biochem Inc

1M 1M
-15%
6M 6M
-24%
1Y 1Y
-57%
3Y 3Y
-68%
5Y 5Y
-70%
10Y 10Y
-75%
Annual Price Range
1.06
52w Low
1.06
52w High
2.66
Price Metrics
Average Annual Return -15.75%
Standard Deviation of Annual Returns 31.12%
Max Drawdown -77%
Shares Statistics
Market Capitalization 53.5m USD
Shares Outstanding 51 230 000
Percentage of Shares Shorted 1.86%

ENZ Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Enzo Biochem Inc Logo
Enzo Biochem Inc

Country

United States of America

Industry

Health Care

Market Cap

53.5m USD

Dividend Yield

0%

Description

Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which focuses on delivering and applying advanced technology capabilities to produce affordable reliable products and services that enable customers to meet their clinical needs. The company is headquartered in Farmingdale, New York and currently employs 451 full-time employees. The firm develops, manufactures and sells technology solutions and platforms to clinical laboratories, specialty clinics, researchers and physicians globally. Enzo's segments include Enzo Clinical Lab, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Lab is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. Enzo Life Sciences manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. Enzo Therapeutics is a biopharmaceutical venture that developed multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases.

Contact

NEW YORK
Farmingdale
60 Executive Blvd
+15167555500.0
http://www.enzo.com/

IPO

1980-06-13

Employees

451

Officers

Chief Executive Officer
Ms. Kara Cannon
Co-Founder & Director
Dr. Elazar Rabbani Ph.D.
Chief Financial Officer
Ms. Patricia Eckert CPA
General Counsel & Secretary
Mr. Matthew Kupferberg

See Also

Discover More
What is the Intrinsic Value of one ENZ stock?

The intrinsic value of one ENZ stock under the Base Case scenario is 1.48 USD.

Is ENZ stock undervalued or overvalued?

Compared to the current market price of 1.06 USD, Enzo Biochem Inc is Undervalued by 28%.